Sandy Spring Bank Bristol Myers Squibb CO Transaction History

Sandy Spring Bank

$2.4 Billion
Q3 2024

A detailed history of Sandy Spring Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sandy Spring Bank holds 93,151 shares of BMY stock, worth $5.48 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

93,151

Previous 102,753 9.34%

Holding current value

$5.48 Million

Previous $4.27 Million 12.96%

% of portfolio

0.2%

Previous 0.19%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$39.66 - $51.75 $380,815 - $496,903	-9,602 Reduced 9.34%	93,151 $4.82 Million
Q2 2024 Aug 06, 2024	SELL	$40.25 - $52.99 $140,714 - $185,253	-3,496 Reduced 3.29%	102,753 $4.27 Million
Q1 2024 May 08, 2024	SELL	$47.98 - $54.4 $142,164 - $161,187	-2,963 Reduced 2.71%	106,249 $5.76 Million
Q4 2023 Jan 26, 2024	SELL	$48.48 - $57.85 $471,516 - $562,649	-9,726 Reduced 8.18%	109,212 $5.6 Million
Q3 2023 Oct 30, 2023	SELL	$57.89 - $64.73 $30,913 - $34,565	-534 Reduced 0.45%	118,938 $6.9 Million
Q2 2023 Aug 04, 2023	SELL	$63.71 - $70.74 $149,718 - $166,239	-2,350 Reduced 1.93%	119,472 $7.64 Million
Q1 2023 May 05, 2023	SELL	$65.71 - $74.53 $110,984 - $125,881	-1,689 Reduced 1.37%	121,822 $8.44 Million
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $306,584 - $363,039	-4,477 Reduced 3.5%	123,511 $8.89 Million
Q3 2022 Nov 02, 2022	SELL	$0.13 - $76.84 $1,206 - $712,844	-9,277 Reduced 6.76%	127,988 $9.1 Million
Q2 2022 Jul 21, 2022	SELL	$72.62 - $79.98 $212,558 - $234,101	-2,927 Reduced 2.09%	137,265 $10.6 Million
Q1 2022 May 03, 2022	SELL	$61.48 - $73.72 $8.38 Million - $10 Million	-136,227 Reduced 49.28%	140,192 $10.2 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $7.19 Million - $8.38 Million	134,052 Added 94.16%	276,419 $17.3 Million
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $102,127 - $119,629	-1,726 Reduced 1.2%	142,367 $8.42 Million
Q2 2021 Aug 09, 2021	BUY	$61.91 - $67.42 $97,755 - $106,456	1,579 Added 1.11%	144,093 $9.63 Million
Q1 2021 May 03, 2021	BUY	$59.34 - $66.74 $318,418 - $358,126	5,366 Added 3.91%	142,514 $9 Million
Q4 2020 Feb 03, 2021	SELL	$57.74 - $65.43 $202,263 - $229,201	-3,503 Reduced 2.49%	137,148 $8.51 Million
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $133,582 - $148,026	2,326 Added 1.68%	140,651 $8.48 Million
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $117,314 - $137,152	2,140 Added 1.57%	138,325 $8.13 Million
Q1 2020 May 01, 2020	SELL	$46.4 - $67.43 $257,241 - $373,831	-5,544 Reduced 3.91%	136,185 $7.59 Million
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $95,811 - $124,977	1,947 Added 1.39%	141,729 $9.1 Million
Q3 2019 Nov 01, 2019	BUY	$42.77 - $50.71 $45,721 - $54,208	1,069 Added 0.77%	139,782 $7.09 Million
Q2 2019 Aug 01, 2019	SELL	$44.62 - $49.34 $197,978 - $218,921	-4,437 Reduced 3.1%	138,713 $6.29 Million
Q1 2019 May 06, 2019	BUY	$45.12 - $53.8 $170,237 - $202,987	3,773 Added 2.71%	143,150 $6.83 Million
Q4 2018 Feb 08, 2019	SELL	$48.76 - $63.23 $203,377 - $263,732	-4,171 Reduced 2.91%	139,377 $7.25 Million
Q3 2018 Nov 07, 2018	BUY	$55.19 - $62.25 $993 - $1,120	18 Added 0.01%	143,548 $8.91 Million
Q2 2018 Aug 03, 2018	BUY	$50.53 - $62.98 $155,430 - $193,726	3,076 Added 2.19%	143,530 $7.94 Million
Q1 2018 May 04, 2018	BUY	$59.92 - $68.98 $657,622 - $757,055	10,975 Added 8.48%	140,454 $8.88 Million
Q4 2017 Feb 02, 2018	BUY	$59.94 - $65.35 $413,586 - $450,914	6,900 Added 5.63%	129,479 $7.93 Million
Q3 2017 Nov 03, 2017	BUY	$55.23 - $63.74 $163,259 - $188,415	2,956 Added 2.47%	122,579 $7.81 Million
Q2 2017 Aug 11, 2017	BUY	N/A	119,623	119,623 $6.71 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.

Account

Sandy Spring Bank Bristol Myers Squibb CO Transaction History